Skip to content

Evaluation of the effects of patching combined visual cognition AR training on amblyopia treatment and behavioral improvement

Evaluation of the effects of patching combined visual cognition AR training on amblyopia treatment and behavioral improvement

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102307
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-05-25
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia

Interventions

Control group:Patching therapy
Training group:AR training + patching therapy

Sponsors

Shenzhen Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Age 6~12 years old, gender is not limited; 2.According to the Expert Consensus on Prevention and Treatment of amblyopia in Chinese Children (2021) by Strabismus and Pediatric Ophthalmology Group of the Chinese Academy of Ophthalmology, 1 the amblyopia should be diagnosed as amblyopia, and the amblyopia should be 0.2 to 0.8. When the amblyopia reaches 0.8, the contralateral eye should reach 1.2 or above; 3.The subjects had monocular amblyopia; 4.Anisometropic amblyopia (visual acuity cannot reach the normal level of this age group after 6 months of wearing glasses alone) or oblique amblyopia (strabisopia has been corrected by surgery, and the postoperative oblique Angle is -5? ~ +10?, measured by SPCT) or the above two mixed amblyopia; 5.The guardian of the subject can understand the purpose of this study, cooperate with the treatment and related eye examination, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Equivalent spherical lens SE <= -6.00D; 2.The subject has tumor, heart disease, hypertension, epilepsy; 3.the subject has an implanted electronic device, such as a pacemaker, in his body; 4.the subject has suffered from mental illness; 5.The subject suffers from severe inflammation, photophobia, and tears at any one glance; 6.the subject suffers from vertigo, fear of heights or brain trauma; 7.The subject's eyes have organic lesions; 8.Received other amblyopia treatment within 24 weeks before enrollment The subject of; 9.Participants had participated in other clinical trials within 24 weeks prior to enrollment; 10.The clinician considers, for safety reasons or in the interests of the patient, that the patient should not participate; 11.Diagnosed as dyschromatism (color deficiency or color blindness);

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;

Secondary

MeasureTime frame
Attention deficit score;Children's ADHD score;Quantitative indicators of visual cognitive information processing;

Countries

China

Contacts

Public ContactHongWei Deng

Shenzhen Eye Hospital

dhw110@126.com+86 135 1009 3392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026